Second Tuesdays, February-June, 2014
6:00 - 7:30 p.m.
Admission: $10 adults; $5 students, seniors. Free with MIT ID. Tickets available at the door.
In this new series at the MIT Museum, meet leaders from new and established Cambridge biotechnologies, and learn about the focus and potential impacts of their company’s research.
February 11: David Schenkein, CEO of Agios: Attacking the Deadly Metabolism of Cancer Cells
March 11: George Scangos, CEO of Biogen IDEC: Facing Up To Difficult Diseases
April 8: Kevin Starr, Partner at Third Rock Ventures: The Investment Crisis in Life Science
May 13: John Maraganore, CEO of Alnylam: RNAi Therapeutics, Alnylam Pharmaceuticals, and The Carrot Seed
June 10: Cancelled.
This program is presented in collaboration with Cambridge At Home.